EcoDrugPlus

Protein Kinase C Epsilon

Ensembl ID : ENSPVAG00000011256
Gene Symbol: PRKCE
1 Cross references
316 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPVAG00000014495
Gene Symbol: PRKCH
1 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSPVAG00000000593
Gene Symbol: PRKCG
1 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPVAG00000014374
Gene Symbol: PRKCI
1 Cross references
195 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPVAG00000015457
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSPVAG00000006922
Gene Symbol: PRKD1
1 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSPVAG00000013838
Gene Symbol: PRKD3
1 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSPVAG00000017556
Gene Symbol: PRKACA
1 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSPVAG00000000499
Gene Symbol: PRKACB
1 Cross references
297 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSPVAG00000015224
Gene Symbol: PRKDC
1 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSPVAG00000002666
Gene Symbol: PPP3CA
1 Cross references
230 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSPVAG00000013240
Gene Symbol: PTK2
1 Cross references
323 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).